tandospirone has been researched along with Autosomal Dominant Striatonigral Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukazawa, T; Hamada, T; Takei, A; Tashiro, K; Yabe, I | 1 |
| Fukazawa, T; Hamada, K; Hamada, T; Honma, S; Kawashima, A; Takei, A; Tashiro, K; Yabe, I | 1 |
2 other study(ies) available for tandospirone and Autosomal Dominant Striatonigral Degeneration
| Article | Year |
|---|---|
'Drug holiday' effects of tandospirone in a patient with Machado-Joseph disease.
Topics: Adult; Humans; Isoindoles; Machado-Joseph Disease; Male; Piperazines; Pyrimidines; Serotonin Receptor Agonists | 2003 |
Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease.
Topics: Anti-Anxiety Agents; Cerebellar Ataxia; Humans; Isoindoles; Machado-Joseph Disease; Male; Middle Aged; Piperazines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Treatment Outcome | 2002 |